Chai Discovery
Building AI models to accelerate pre-clinical drug discovery
$400MSeries C
Role not disclosedLoading investors…
Activity from announced rounds
Building AI models to accelerate pre-clinical drug discovery
Develops non-invasive histotripsy platform using focused ultrasound to mechanically destroy tumors without surgery
Provides a healthcare pricing and payment platform to streamline contracts and transactions
Develops AI-driven drug discovery platform for first- and best-in-class therapeutics
Develops AI-driven drug discovery for proximity therapeutics